Strong Wall Street Debut Shows Potential Of Indian Billionaire-Backed Bicara’s Cancer Drugs
Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% ...
Wall Street’s $5.1 Trillion Triple-Witching Is Next Market Test
Just as Wall Street traders come to grips with the Federal Reserve’s interest-rate cut, Friday’s US options expiration ...
Wall Street Breakfast: Lower For Longer
Read more about the Fed's policy stance shift, Nike CEO exit, Disney's move to stop using Slack, and FedEx earnings and ...
John Paulson brushes aside Wall Street worries about Donald Trump’s tariff plan
Billionaire hedge fund manager John Paulson has brushed aside Wall Street worries that Donald Trump’s plans to raise tariffs ...
Why a top analyst just raised his year-end S&P 500 price target to the highest on Wall Street
"A soft landing is the most likely economic scenario which makes the current environment most comparable to the mid-1990s," ...
Wall Street Breakfast: Fool Me Once
Stay updated on the latest financial news with Wall Street Breakfast podcast available on Seeking Alpha, iTunes, and Spotify.
India's Nifty, Sensex outperform most global markets, behind only Wall Street
India's NSE Nifty 50 and S&P BSE Sensex are trailing only Wall Street's Nasdaq and S&P 500 as top-performing indexes this ...